Are you Dr. Marek?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 65 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
60 Temple St
New Haven, CT 06510Phone+1 203-401-4300Fax+1 203-401-4301
Summary
- Dr. Kenneth Marek, MD is a board certified neurologist in New Haven, Connecticut. He is currently licensed to practice medicine in Connecticut and Maryland. He is affiliated with Yale-New Haven Hospital.
Education & Training
Johns Hopkins UniversityResidency, Neurology, 1984 - 1986- Johns Hopkins UniversityResidency, Internal Medicine, 1982 - 1984
- Johns Hopkins UniversityInternship, Internal Medicine, 1978 - 1979
Yale School of MedicineClass of 1978
Certifications & Licensure
CT State Medical License 1989 - 2025
MD State Medical License 1985 - 1989- American Board of Internal Medicine Internal Medicine
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease Start of enrollment: 2003 May 01
- Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease Start of enrollment: 2005 Jan 01
- Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome Start of enrollment: 1992 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial.Gennaro Pagano, Annabelle Monnet, Adriana Reyes, Benjamin Ribba, Hanno Svoboda
Nature Medicine. 2024-12-01 - Accelerating Parkinson's Disease drug development with federated learning approaches.Amit Khanna, Jamie Adams, Chrystalina Antoniades, Bastiaan R Bloem, Camille Carroll
NPJ Parkinson's Disease. 2024-11-21 - Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts.Tien Dam, Gennaro Pagano, Michael C Brumm, Caroline Gochanour, Kathleen L Poston
NPJ Parkinson's Disease. 2024-09-27
Press Mentions
Michael J. Fox Foundation Discovers Breakthrough in Search for Parkinson’s BiomarkerApril 17th, 2023- Parkinson’s Test Flags Early DiseaseApril 13th, 2023
- ‘Game-Changing’ New Parkinson’s Test Paves Way for Treatments and CureApril 12th, 2023
- Join now to see all
Professional Memberships
- Member
